References
- Lizneva D, Suturina L, Walker W, et al. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Steril. [Internet]. 2016 [cited 2019 Sep 27];106:6–15. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27233760
- Yildiz BO, Bozdag G, Yapici Z, et al. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria. Hum Reprod. [Internet]. 2012 [cited 2016 Apr 13];27:3067–3073. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22777527
- Zawadzki JKDA. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: dunaif AGJ, Haseltine F (eds). Polycystic ovary syndrome. Bost Blackwell Sci. 1992;377–384.
- Azziz R, Carmina E, Dewailly D, et al. The androgen excess and PCOS society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. [Internet]. 2009 [cited 2019 Sep 27];91:456–488. Available from http://www.ncbi.nlm.nih.gov/pubmed/18950759
- Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. [Internet]. 2004 cited 2019 Sep 27;81:19–25. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14711538.
- Johnson TRB, Kaplan LK, Ouyang P, et al. National Institute of health evidence-based methodology workshop on polycystic ovary syndrome. Natl Institutes Heal. [Internet]. 2012;1–14. Available from https://prevention.nih.gov/docs/programs/pcos/FinalReport.pdf
- Wild RA, Carmina E, Diamanti-Kandarakis E, et al. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the androgen excess and polycystic ovary syndrome (AE-PCOS) society. J Clin Endocrinol Metab. [Internet]. 2010 [cited 2019 Sep 27];95:2038–2049. Available from http://www.ncbi.nlm.nih.gov/pubmed/20375205
- Brown ZA, Louwers YV, Fong SL, et al. The phenotype of polycystic ovary syndrome ameliorates with aging. Fertil Steril. [Internet]. 2011 [cited 2019 Sep 27];96:1259–1265. Available from http://www.ncbi.nlm.nih.gov/pubmed/21963227
- Elting MW, Korsen TJM, Rekers-Mombarg LTM, et al. Women with polycystic ovary syndrome gain regular menstrual cycles when ageing. Hum Reprod. [Internet]. 2000 [cited 2019 Sep 27];15:24–28. Available from http://www.ncbi.nlm.nih.gov/pubmed/10611183
- Alsamarai S, Adams JM, Murphy MK, et al. Criteria for polycystic ovarian morphology in polycystic ovary syndrome as a function of age. J Clin Endocrinol Metab. [Internet]. 2009 [cited 2019 Sep 27];94:4961–4970. Available from http://www.ncbi.nlm.nih.gov/pubmed/19846740
- Winters SJ, Talbott E, Guzick DS, et al. Serum testosterone levels decrease in middle age in women with the polycystic ovary syndrome. Fertil Steril. [Internet]. 2000 [cited 2019 Sep 27];73:724–729. Available from http://www.ncbi.nlm.nih.gov/pubmed/10731532
- Carmina E, Campagna AM, Lobo RA. A 20-year follow-up of young women with polycystic ovary syndrome. Obstet Gynecol. [Internet]. 2012;119:263–269. [cited 2019 Sep 27]. Available from http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00006250-201202000-00010.
- Markopoulos MC, Rizos D, Valsamakis G, et al. Hyperandrogenism in women with polycystic ovary syndrome persists after menopause. J Clin Endocrinol Metab. [Internet]. 2011 [cited 2019 Sep 27];96:623–631. Available from http://www.ncbi.nlm.nih.gov/pubmed/21177795
- Legro RS, Arslanian SA, Ehrmann DA, et al. Diagnosis and treatment of polycystic ovary syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. [Internet]. 2013 [cited 2019 Sep 27];98:4565–4592. Available from http://www.ncbi.nlm.nih.gov/pubmed/24151290
- Lim SS, Davies MJ, Norman RJ, et al. Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. [Internet]. 2012 [cited 2019 Sep 27];18:618–637. Available from.http://www.ncbi.nlm.nih.gov/pubmed/22767467
- Legro RS, Kunselman AR, Dunaif A. Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome. Am J Med. [Internet]. 2001;111:607–613. [cited 2019 Sep 27]. Available from http://www.ncbi.nlm.nih.gov/pubmed/11755503
- Wild RA, Rizzo M, Clifton S, et al. Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis. Fertil Steril. [Internet]. 2011 [cited 2019 Sep 27];95:1073–1079.e11. Available from http://www.ncbi.nlm.nih.gov/pubmed/21247558
- Pinola P, Puukka K, Piltonen TT, et al. Normo- and hyperandrogenic women with polycystic ovary syndrome exhibit an adverse metabolic profile through life. Fertil Steril. [Internet]. 2017 [cited 2019 Sep 27];107:788–795.e2. Available from http://www.ncbi.nlm.nih.gov/pubmed/28089571
- Kahn R Consen sus development conference on insulin resistance: 5–6 November 1997. Diabetes Care. American Diabetes Association Inc.; 1998. p. 310–314.
- Stepto NK, Cassar S, Joham AE, et al. Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp. Hum Reprod. [Internet]. 2013 [cited 2019 Sep 27];28:777–784. Available from http://www.ncbi.nlm.nih.gov/pubmed/23315061
- Azziz R, Carmina E, Chen Z, et al. Polycystic ovary syndrome. Nat Rev Dis Prim. [Internet]. 2016 [cited 2019 Oct 7];2:16057. Available from http://www.nature.com/articles/nrdp201657
- Moran LJ, Misso ML, Wild RA, et al. Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. Internet. 2010 [cited 2019 Sep 27];16:347–363. Available from.http://www.ncbi.nlm.nih.gov/pubmed/20159883
- Kakoly NS, Khomami MB, Joham AE, et al. Ethnicity, obesity and the prevalence of impaired glucose tolerance and type 2 diabetes in PCOS: a systematic review and meta-regression. Hum Reprod Update. [Internet]. 2018 [cited 2019 Sep 27];24:455–467. Available from http://www.ncbi.nlm.nih.gov/pubmed/29590375
- Rubin KH, Glintborg D, Nybo M, et al. Development and risk factors of type 2 diabetes in a nationwide population of women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2017;102:3848–3857.
- Alberti KGMM, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640–1645.
- Lim SS, Kakoly NS, Tan JWJ, et al. Metabolic syndrome in polycystic ovary syndrome: a systematic review, meta-analysis and meta-regression. Obes Rev. [Internet]. 2019 [cited 2019 Sep 27];20:339–352. Available from http://www.ncbi.nlm.nih.gov/pubmed/30339316
- Toulis KA, Goulis DG, Mintziori G, et al. Meta-analysis of cardiovascular disease risk markers in women with polycystic ovary syndrome. Hum Reprod Update. Internet. 2011 [cited 2019 Sep 27];17:741–760. Available from.http://www.ncbi.nlm.nih.gov/pubmed/21628302
- Yildiz BO, Haznedaroglu İC, Kirazli Ş, et al. Global fibrinolytic capacity is decreased in polycystic ovary syndrome, suggesting a prothrombotic state. J Clin Endocrinol Metab. [Internet]. 2002 [cited 2019 Sep 27];87:3871–3875. Available from http://www.ncbi.nlm.nih.gov/pubmed/12161525
- Meyer ML, Malek AM, Wild RA, et al. Carotid artery intima-media thickness in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. Internet. 2012 [cited 2019 Sep 27];18:112–126. Available from.http://www.ncbi.nlm.nih.gov/pubmed/22108382
- Calderon-Margalit R, Siscovick D, Merkin SS, et al. Prospective association of polycystic ovary syndrome with coronary artery calcification and carotid-intima-media thickness. Arterioscler Thromb Vasc Biol. [Internet]. 2014 [cited 2019 Sep 27];34:2688–2694. Available from http://www.ncbi.nlm.nih.gov/pubmed/25359859
- Sprung VS, Atkinson G, Cuthbertson DJ, et al. Endothelial function measured using flow-mediated dilation in polycystic ovary syndrome: a meta-analysis of the observational studies. Clin Endocrinol (Oxf). [Internet]. 2013 [cited 2019 Sep 27];78:438–446. Available from http://www.ncbi.nlm.nih.gov/pubmed/22775449
- Lee CG, Carr MC, Murdoch SJ, et al. Adipokines, inflammation, and visceral adiposity across the menopausal transition: a prospective study. J Clin Endocrinol Metab. [Internet]. 2009 [cited 2019 Sep 27];94:1104–1110. Available from http://www.ncbi.nlm.nih.gov/pubmed/19126626
- Matthews KA, Crawford SL, Chae CU, et al. Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition? J Am Coll Cardiol. [Internet]. 2009 [cited 2019 Sep 27];54:2366–2373. Available from http://www.ncbi.nlm.nih.gov/pubmed/20082925
- Mumusoglu S, Yildiz BO. Metabolic syndrome during menopause. Curr Vasc Pharmacol. [Internet]. 2018 [cited 2019 Sep 27];16. Available from http://www.ncbi.nlm.nih.gov/pubmed/30179134
- Echiburú B, Crisosto N, Maliqueo M, et al. Metabolic profile in women with polycystic ovary syndrome across adult life. Metabolism. 2016;65:776–782.
- Kazemi Jaliseh H, Ramezani Tehrani F, Behboudi-Gandevani S, et al. Polycystic ovary syndrome is a risk factor for diabetes and prediabetes in middle-aged but not elderly women: a long-term population-based follow-up study. Fertil Steril. [Internet]. 2017 [cited 2019 Sep 27];108:1078–1084. Available from http://www.ncbi.nlm.nih.gov/pubmed/29202960
- Behboudi-Gandevani S, Ramezani Tehrani F, Hosseinpanah F, et al. Cardiometabolic risks in polycystic ovary syndrome: long-term population-based follow-up study. Fertil Steril. [Internet]. 2018 [cited 2019 Sep 27];110:1377–1386. Available from http://www.ncbi.nlm.nih.gov/pubmed/30503137
- Schmidt J, Brännström M, Landin-Wilhelmsen K, et al. Reproductive hormone levels and anthropometry in postmenopausal women with polycystic ovary syndrome (PCOS): a 21-year follow-up study of women diagnosed with PCOS around 50 years ago and their age-matched controls. J Clin Endocrinol Metab. [Internet]. 2011 [cited 2019 Sep 27];96:2178–2185. Available from https://academic.oup.com/jcem/article-lookup/doi/10.1210/jc.2010-2959
- Schmidt J, Landin-Wilhelmsen K, Brännström M, et al. Cardiovascular disease and risk factors in PCOS women of postmenopausal age: a 21-year controlled follow-up study. J Clin Endocrinol Metab. [Internet]. 2011;96:3794–3803. [cited 2019 Sep 27]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21956415
- Wild S, Pierpoint T, McKeigue P, et al. Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study. Clin Endocrinol (Oxf). [Internet]. 2000 [cited 2019 Sep 27];52:595–600. Available from http://www.ncbi.nlm.nih.gov/pubmed/10792339
- Iftikhar S, Collazo-Clavell ML, Roger VL, et al. Risk of cardiovascular events in patients with polycystic ovary syndrome. Neth J Med. [Internet]. 2012 [cited 2019 Sep 27];70:74–80. Available from http://www.ncbi.nlm.nih.gov/pubmed/22418753
- Polotsky AJ, Allshouse AA, Crawford SL, et al. Hyperandrogenic oligomenorrhea and metabolic risks across menopausal transition. J Clin Endocrinol Metab. [Internet]. 2014 [cited 2019 Sep 27];99:2120–2127. Available from http://www.ncbi.nlm.nih.gov/pubmed/24517154
- Pierpoint T, McKeigue PM, Isaacs AJ, et al. Mortality of women with polycystic ovary syndrome at long-term follow-up. J Clin Epidemiol. [Internet]. 1998 [cited 2019 Sep 27];51:581–586. Available from http://www.ncbi.nlm.nih.gov/pubmed/9674665
- Mani H, Levy MJ, Davies MJ, et al. Diabetes and cardiovascular events in women with polycystic ovary syndrome: a 20-year retrospective cohort study. Clin Endocrinol (Oxf). [Internet]. 2013 [cited 2019 Sep 27];78:926–934. Available from http://www.ncbi.nlm.nih.gov/pubmed/23046078
- Hart R, Doherty DA. The potential implications of a PCOS diagnosis on a woman’s long-term health using data linkage. J Clin Endocrinol Metab. [Internet]. 2015;100:911–919. [cited 2019 Sep 27]. Available from http://www.ncbi.nlm.nih.gov/pubmed/25532045
- Glintborg D, Rubin KH, Nybo M, et al. Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome. Cardiovasc Diabetol. [Internet]. 2018;17:37. [cited 2019 Sep 27]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29519249
- Wild RA, Grubb B, Hartz A, et al. Clinical signs of androgen excess as risk factors for coronary artery disease. Fertil Steril. [Internet]. 1990 [cited 2019 Sep 27];54:255–259. Available from http://www.ncbi.nlm.nih.gov/pubmed/2143147
- Birdsall MA, Farquhar CM, White HD. Association between polycystic ovaries and extent of coronary artery disease in women having cardiac catheterization. Ann Intern Med. [Internet]. 1997;126:32. cited 2019 Sep 27. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8992921.
- Cibula D, Cífková R, Fanta M, et al. Increased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndrome. Hum Reprod. [Internet]. 2000 [cited 2019 Sep 27];15:785–789. Available from http://www.ncbi.nlm.nih.gov/pubmed/10739820
- Krentz AJ, von Mühlen D, Barrett-Connor E. Searching for polycystic ovary syndrome in postmenopausal women: evidence of a dose-effect association with prevalent cardiovascular disease. Menopause. Internet. 2007 [cited 2019 Sep 27];14:284–292. Available from.http://www.ncbi.nlm.nih.gov/pubmed/17245231
- Shaw LJ, Bairey Merz CN, Azziz R, et al. Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the national institutes of health—national heart, lung, and blood institute sponsored wo. J Clin Endocrinol Metab. [Internet]. 2008 [cited 2019 Sep 27];93:1276–1284. Available from http://www.ncbi.nlm.nih.gov/pubmed/18182456
- Merz CNB, Shaw LJ, Azziz R, et al. Cardiovascular disease and 10-year mortality in postmenopausal women with clinical features of polycystic ovary syndrome. J Womens Health (Larchmt). [Internet]. 2016 [cited 2019 Sep 27];25:875–881. Available from http://www.liebertpub.com/doi/10.1089/jwh.2015.5441
- Meun C, Franco OH, Dhana K, et al. High androgens in postmenopausal women and the risk for atherosclerosis and cardiovascular disease: the rotterdam study. J Clin Endocrinol Metab. [Internet]. 2018 [cited 2019 Sep 27];103:1622–1630. Available from http://www.ncbi.nlm.nih.gov/pubmed/29408955
- Solomon CG, Hu FB, Dunaif A, et al. Menstrual cycle irregularity and risk for future cardiovascular disease. J Clin Endocrinol Metab. [Internet]. 2002;87:2013–2017. [cited 2019 Sep 27]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11994334
- Wang ET, Cirillo PM, Vittinghoff E, et al. Menstrual irregularity and cardiovascular mortality. J Clin Endocrinol Metab. [Internet]. 2011 [cited 2019 Sep 27];96:E114–E118. Available from http://www.ncbi.nlm.nih.gov/pubmed/20980429
- Gast G-CM, Grobbee DE, Smit HA, et al. Menstrual cycle characteristics and risk of coronary heart disease and type 2 diabetes. Fertil Steril. [Internet]. 2010 [cited 2019 Sep 27];94:2379–2381. Available from http://www.ncbi.nlm.nih.gov/pubmed/20451189
- Anderson SA, Barry JA, Hardiman PJ. Risk of coronary heart disease and risk of stroke in women with polycystic ovary syndrome: a systematic review and meta-analysis. Int J Cardiol. [Internet]. 2014;176:486–487. [cited 2019 Sep 27]. Available from https://linkinghub.elsevier.com/retrieve/pii/S0167527314011668
- de Groot PCM, Dekkers OM, Romijn JA, et al. PCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysis. Hum Reprod Update. [Internet]. 2011 [cited 2019 Sep 27];17:495–500. Available from http://www.ncbi.nlm.nih.gov/pubmed/21335359
- Zhao L, Zhu Z, Lou H, et al. Polycystic ovary syndrome (PCOS) and the risk of coronary heart disease (CHD): a meta-analysis. Oncotarget. Internet. 2016 [cited 2019 Sep 27];7:33715–33721. Available from.http://www.ncbi.nlm.nih.gov/pubmed/27220885
- Zhou Y, Wang X, Jiang Y, et al. Association between polycystic ovary syndrome and the risk of stroke and all-cause mortality: insights from a meta-analysis. Gynecol Endocrinol. [Internet]. 2017 [cited 2019 Oct 7];33:904–910. Available from http://www.ncbi.nlm.nih.gov/pubmed/28696807
- Helena T, Marie M, Michael C, et al. Moran Lisa PT and NR. International evidence-based guideline for the assessment and management of polycystic ovary syndrome Internet. 2018 [cited 2019 Sep 27]. Available from. https://www.monash.edu/__data/assets/pdf_file/0004/1412644/PCOS_Evidence-Based-Guidelines_20181009.pdf.
- Ramezani Tehrani F, Amiri M, Behboudi-Gandevani S, et al. Cardiovascular events among reproductive and menopausal age women with polycystic ovary syndrome: a systematic review and meta-analysis. Gynecol Endocrinol. [Internet]. 2019 cited 2019 Dec 11;1–12. Available from: http://www.ncbi.nlm.nih.gov/pubmed/31385729
- Escobar-Morreale HF. The role of androgen excess in metabolic dysfunction in women. Adv Exp Med Biol. [Internet]. 2017;597–608. [cited 2019 Sep 27]. p. . Available from: http://www.ncbi.nlm.nih.gov/pubmed/29224112.
- Nestler JE, Jakubowicz DJ, Falcon de Vargas A, et al. Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system. J Clin Endocrinol Metab. [Internet]. 1998 [cited 2019 Sep 27];83:2001–2005. Available from http://www.ncbi.nlm.nih.gov/pubmed/9626131
- NESTLER JE, POWERS LP, MATT DW, et al. A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome. J Clin Endocrinol Metab. [Internet]. 1991 [cited 2019 Sep 27];72:83–89. Available from http://www.ncbi.nlm.nih.gov/pubmed/1898744
- Guastella E, Longo RA, Carmina E. Clinical and endocrine characteristics of the main polycystic ovary syndrome phenotypes. Fertil Steril. [Internet]. 2010;94:2197–2201. [cited 2019 Sep 27]. Available from http://www.ncbi.nlm.nih.gov/pubmed/20303485
- Daan NMP, Louwers YV, Koster MPH, et al. Cardiovascular and metabolic profiles amongst different polycystic ovary syndrome phenotypes: who is really at risk? Fertil Steril. [Internet]. 2014;102:1444–1451.e3. [cited 2019 Sep 27]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25239303
- Ouyang P, Vaidya D, Dobs A, et al. Sex hormone levels and subclinical atherosclerosis in postmenopausal women: the multi-ethnic study of atherosclerosis. Atherosclerosis. [Internet]. 2009;204:255–261. [cited 2019 Sep 27]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18849030
- Creatsa M, Armeni E, Stamatelopoulos K, et al. Circulating androgen levels are associated with subclinical atherosclerosis and arterial stiffness in healthy recently menopausal women. Metabolism. [Internet]. 2012 [cited 2019 Sep 27];61:193–201. Available from https://linkinghub.elsevier.com/retrieve/pii/S002604951100179X
- Armeni E, Stamatelopoulos K, Rizos D, et al. Arterial stiffness is increased in asymptomatic nondiabetic postmenopausal women with a polycystic ovary syndrome phenotype. J Hypertens. [Internet]. 2013 [cited 2019 Sep 27];31:1998–2004. Available from http://www.ncbi.nlm.nih.gov/pubmed/24107731
- Benn M, Voss SS, Holmegard HN, et al. Extreme concentrations of endogenous sex hormones, ischemic heart disease, and death in women. Arterioscler Thromb Vasc Biol. [Internet]. 2015 [cited 2019 Sep 27];35:471–477. Available from https://www.ahajournals.org/doi/10.1161/ATVBAHA.114.304821
- Laughlin GA, Goodell V, Barrett-Connor E. Extremes of endogenous testosterone are associated with increased risk of incident coronary events in older women. J Clin Endocrinol Metab. [Internet]. 2010;95:740–747. [cited 2019 Sep 27]. Available from http://www.ncbi.nlm.nih.gov/pubmed/19934360
- Patel SM, Ratcliffe SJ, Reilly MP, et al. Higher serum testosterone concentration in older women is associated with insulin resistance, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab. [Internet]. 2009 [cited 2019 Sep 27];94:4776–4784. Available from http://www.ncbi.nlm.nih.gov/pubmed/19846742
- Sievers C, Klotsche J, Pieper L, et al. Low testosterone levels predict all-cause mortality and cardiovascular events in women: a prospective cohort study in German primary care patients. Eur J Endocrinol. [Internet]. 2010 [cited 2019 Sep 28];163:699–708. Available from https://eje.bioscientifica.com/view/journals/eje/163/4/699.xml
- Wehr E, Pilz S, Boehm BO, et al. Low free testosterone levels are associated with all-cause and cardiovascular mortality in postmenopausal diabetic women. Diabetes Care. Internet. 2011 [cited 2019 Sep 28];34:1771–1777. Available from.http://www.ncbi.nlm.nih.gov/pubmed/21715525
- Schaffrath G, Kische H, Gross S, et al. Association of sex hormones with incident 10-year cardiovascular disease and mortality in women. Maturitas. Internet. 2015 [cited 2019 Sep 28];82:424–430. Available from.https://linkinghub.elsevier.com/retrieve/pii/S037851221530044X
- Rexrode KM, Manson JE, Lee I-M, et al. Sex hormone levels and risk of cardiovascular events in postmenopausal women. Circulation. Internet. 2003 [cited 2019 Sep 28];108:1688–1693. Available from.https://www.ahajournals.org/doi/10.1161/01.CIR.0000091114.36254.F3
- Zhao D, Guallar E, Ouyang P, et al. Endogenous sex hormones and incident cardiovascular disease in post-menopausal women. J Am Coll Cardiol. [Internet]. 2018 [cited 2019 Sep 28];71:2555–2566. Available from https://linkinghub.elsevier.com/retrieve/pii/S0735109718343614
- Zoet GA, Meun C, Benschop L, et al. Cardiovascular RiskprofilE - IMaging and gender-specific disOrders (CREw-IMAGO): rationale and design of a multicenter cohort study. BMC Womens Health. [Internet]. 2017 [cited 2019 Oct 7];17:60. Available from http://www.ncbi.nlm.nih.gov/pubmed/28784118
- Yildiz BO. Approach to the patient: contraception in women with polycystic ovary syndrome. J Clin Endocrinol Metab. [Internet]. 2015;100:794–802. [cited 2019 Oct 7]. Available from https://academic.oup.com/jcem/article-lookup/doi/10.1210/jc.2014-3196
- Bairey Merz CN, Johnson BD, Berga S, et al. Past oral contraceptive use and angiographic coronary artery disease in postmenopausal women: data from the national heart, lung, and blood institute–sponsored women’s ischemia syndrome evaluation. Fertil Steril. [Internet]. 2006 [cited 2019 Oct 7];85:1425–1431. Available from http://www.ncbi.nlm.nih.gov/pubmed/16600235
- Teede HJ, Misso ML, Costello MF, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil Steril. [Internet]. 2018 [cited 2019 Sep 28];110:364–379. Available from http://www.ncbi.nlm.nih.gov/pubmed/30033227